Kbc Group Nv Qiagen N.V. Transaction History

Kbc Group Nv

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$42.19 - $45.27 $470,165 - $504,488	-11,144 Closed	0 $0
Q4 2023 Feb 13, 2024	BUY	$35.55 - $43.57 $59,439 - $72,849	1,672 Added 17.65%	11,144 $484,000
Q3 2023 Feb 15, 2024	BUY	$39.13 - $47.24 $32,477 - $39,209	830 Added 8.76%	10,302 $417,000
Q2 2023 Feb 15, 2024	BUY	$43.93 - $46.76 $18,977 - $20,200	432 Added 4.78%	9,472 $427,000
Q2 2023 Jul 28, 2023	BUY	$43.93 - $46.76 $199,222 - $212,056	4,535 Added 91.86%	9,472 $427,000
Q1 2023 Feb 14, 2024	BUY	$45.29 - $50.76 $24,230 - $27,156	535 Added 12.15%	4,937 $227,000
Q1 2023 May 04, 2023	BUY	$45.29 - $50.76 $59,465 - $66,647	1,313 Added 36.23%	4,937 $227,000
Q4 2022 Feb 14, 2024	SELL	$41.91 - $50.48 $118,521 - $142,757	-2,828 Reduced 39.11%	4,402 $220,000
Q3 2022 Feb 15, 2024	SELL	$40.9 - $50.42 $86,053 - $106,083	-2,104 Reduced 18.88%	9,040 $374,000
Q3 2022 Nov 08, 2022	BUY	$40.9 - $50.42 $4,826 - $5,949	118 Added 3.37%	3,624 $150,000
Q2 2022 Feb 14, 2024	BUY	$42.98 - $49.77 $163,495 - $189,325	3,804 Added 111.03%	7,230 $341,000
Q2 2022 Jul 26, 2022	BUY	$42.98 - $49.77 $3,438 - $3,981	80 Added 2.34%	3,506 $165,000
Q1 2022 Feb 14, 2024	BUY	$42.23 - $54.3 $42,483 - $54,625	1,006 Added 41.57%	3,426 $168,000
Q1 2022 May 06, 2022	BUY	$42.23 - $54.3 $42,483 - $54,625	1,006 Added 41.57%	3,426 $168,000
Q4 2021 Feb 14, 2024	SELL	$50.62 - $56.47 $441,608 - $492,644	-8,724 Reduced 78.28%	2,420 $135,000
Q4 2021 Feb 03, 2022	BUY	$50.62 - $56.47 $122,500 - $136,657	2,420 New	2,420 $135,000

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.85B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.